Symbols

BTSG

BrightSpring Health·NASDAQ

--(--)

BTSG fundamentals

BTSG Q4 2025 Earnings

BrightSpring Health (BTSG) released its earnings on Feb 27, 2026: revenue was 3.55B (YoY +16.31%), beat estimates; EPS was 0.33 (YoY +50.00%), missed estimates.

Revenue / YoY

3.55B

+16.31%

EPS / YoY

0.33

+50.00%

Report date

Feb 27, 2026

BTSG Earnings Call Summary for Q4,2025

Strategic Restructuring: $715M Community Living divestiture to reduce leverage and focus on core markets.
Acquisition Growth: $239M Amedisys/LHC acquisition adds 107 branches, driving 2026 EBITDA contribution of $30M.
2025 Performance: 28% revenue growth to $12.9B, 34% EBITDA growth to $618M, with Pharmacy Solutions leading at 31% growth.
2026 Guidance: 14% revenue growth to $14.45B-$15.0B, 25% EBITDA growth to $760M-$790M, supported by LDD pipeline and operational efficiency.
Margin Expansion: Provider Services margin target 17%, Pharmacy Solutions margin improvement from mix shift and cost controls.

Earnings

EPS

Revenue

Revenue & Expenses

BTSG has released its 2025 Q4 earnings report, with revenue of 3.55B, reflecting a YoY change of 29.26%, and net profit of 77.32M, showing a YoY change of 401.95%. The Sankey diagram below clearly presents BTSG's revenue sources and cost distribution.

Key Indicators

BrightSpring Health (BTSG) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

BrightSpring Health (BTSG)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

BrightSpring Health (BTSG)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

BrightSpring Health (BTSG)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown